Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,392	$ 1,565
Investments and restricted cash and cash equivalents	216	1,253
Trade receivables, net	2,551	2,667
Inventories	1,962	1,509
Mortgage loans held for sale	528	451
Regulatory assets	1,136	1,398
Other current assets	1,314	1,355
Total current assets	9,099	10,198
Property, plant and equipment, net	103,769	99,248
Goodwill	11,413	11,547
Regulatory assets	4,213	4,167
Investments and restricted cash and cash equivalents and investments	8,635	9,510
Other assets	3,011	3,170
Total assets	140,140	137,840
Current liabilities:
Accounts payable	2,928	3,175
Accrued interest	728	625
Accrued property, income and other taxes	1,043	828
Accrued employee expenses	364	354
Short-term debt	1,123	4,148
Current portion of long-term debt	2,646	2,740
Other current liabilities	2,109	1,551
Total current liabilities	10,941	13,421
BHE senior debt	11,457	13,101
BHE junior subordinated debentures	0	100
Subsidiary debt	41,154	36,231
Regulatory liabilities	6,754	6,644
Deferred income taxes	12,628	12,437
Other long-term liabilities	5,917	6,166
Total liabilities	88,851	88,100
Commitments and contingencies
Shareholders' equity:
Preferred stock	481	0
Common stock	0	0
Additional paid-in capital	5,558	5,573
Retained earnings	46,311	44,765
Accumulated other comprehensive loss, net	(2,341)	(1,904)
Total shareholder's equity	50,009	48,434
Noncontrolling interests	1,280	1,306
Total equity	51,289	49,740
Total liabilities and shareholder's equity	$ 140,140	$ 137,840